Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label now shows v3.5.4 instead of v3.5.3, indicating a minor update to the ClinicalTrials.gov entry without altering the study details or data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision tag 'Revision: v3.5.3' was added and the previous tag 'Revision: v3.5.2' was removed, updating the page's revision history. This change represents an update to the page version rather than any modification to the study content or data.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page. This is a minor version control update and does not alter study content, eligibility criteria, outcomes, or enrollment details.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded 'Familial multiple polyposis syndrome' and removed 'Classic familial adenomatous polyposis' from the page terminology. The update aligns disease terminology with current references without changing any study details.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3. This is a versioning update and does not affect study content or user-facing features.SummaryDifference0.1%

- Check65 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3. This is a metadata change rather than a modification to the main content.SummaryDifference0.1%

Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.